Medical Disorders
Resources
Basic InformationLookupsLatest News
Heading to Europe This Summer? Get Your Measles ShotAiling Heart Can Speed the Brain's Decline, Study FindsHealth Tip: Preventing GlaucomaHead Injuries Tied to Motorized Scooters Are Rising: StudyOverweight Kids Are at Risk for High Blood PressureHot Water Soak May Help Ease Poor Leg CirculationHealth Tip: Understanding RosaceaHealth Tip: Causes of Swollen Lymph NodesAHA News: Study Provides Rare Look at Stroke Risk, Survival Among American IndiansScared Safe: Pics of Sun's Damage to Face Boost Sunscreen UseNo Needle Prick: Laser-Based Test Hunts Stray Melanoma Cells in BloodBats Are Biggest Rabies Danger, CDC SaysEmgality Receives First FDA Approval for Treating Cluster HeadacheZerbaxa Approved for Hospital-Acquired Bacterial PneumoniaBlood From Previously Pregnant Women Is Safe for Donation: StudyStudy Refutes Notion That People on Warfarin Shouldn't Eat Leafy GreensCancer Survivors Predicted to Top 22 Million by 2030Your Guide to a Healthier Home for Better Asthma ControlHigh Blood Pressure at Doctor's Office May Be More Dangerous Than SuspectedAHA News: 3 Simple Steps Could Save 94 Million Lives WorldwideHealth Tip: Dealing With Motion SicknessHealth Tip: Symptoms of MeningitisRace Affects Life Expectancy in Major U.S. CitiesVitamin D Supplements Don't Prevent Type 2 Diabetes: StudyChickenpox Vaccine Shields Kids From Shingles, TooWhooping Cough Vaccine Effectiveness Fades With Time: StudyHealth Tip: Early Signs of Lyme DiseaseHealth Tip: Hiccup Home RemediesSheep Study Shows a Stuffy Side Effect of VapingShould Air Quality Checks Be Part of Your Travel Planning?Health Tip: Preventing Swimmer's EarHeartburn Drugs Again Tied to Fatal RisksHealth Tip: Nasal Spray SafetyFDA Approves First Drug to Help Tame Cluster HeadachesMany Dietary Supplements Dangerous for TeensAverage American Ingests 70,000 Bits of Microplastic Each YearFalls Are Increasingly Lethal for Older AmericansChicken No Better Than Beef for Your Cholesterol?Another Use for Beta Blockers? Curbing A-fibCaffeine, Nicotine Withdrawal Can Cause Problems in the ICU: StudyYounger Gout Patients Have Higher Odds for Blood ClotsFDA Approves First Test for Zika in Human BloodCDC Warns Again of Salmonella From Pet HedgehogsWhy Some Kids With Eczema Are at Higher Allergy RiskU.S. Measles Cases for 2019 Already Exceed All Annual Totals Since 1992: CDCForget Fasting Before That Cholesterol TestU.S. Cancer Cases, Deaths Continue to Fall'Controlled Burns' Better for Kids' Health Than Wildfires: StudyHighly Processed Diets Tied to Heart Disease, Earlier DeathHealth Tip: Signs of Irritable Bowel Syndrome
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Lungs, Hearts Infected With Hepatitis C Still OK for Transplant

HealthDay News
by By Dennis ThompsonHealthDay Reporter
Updated: Apr 3rd 2019

new article illustration

WEDNESDAY, April 3, 2019 (HealthDay News) -- Patients in dire need of an organ transplant can safely receive a new heart or lung from donors who have hepatitis C, a new clinical trial has shown.

By swiftly administering powerful antiviral drugs, doctors can prevent the organ recipient from contracting hepatitis C following their transplant, said lead researcher Dr. Ann Woolley. She's an infectious disease doctor with Brigham and Women's Hospital in Boston.

None of the first 35 transplant patients enrolled in the trial program have any detectable levels of hepatitis C virus in their bloodstream after at least six months, Woolley said. Additionally, she said all of their new organs are in fine working order.

The breakthrough strategy could increase the number of potential organs available to patients by 20% to 25%, Woolley said.

"We saw in our center alone that of all the transplants we've done in the past two years, over a third of them have been from hepatitis C-positive donors," Woolley said.

Although the number of organ transplants in the United States has increased by 20% over the past five years, it's estimated that about 1,000 people die annually waiting for a new heart or lung, the researchers said in background notes.

Organs typically are washed out as much as possible before transplant, but there's always a microscopic amount of donor blood within them, Woolley said. Within that blood lies the risk of hepatitis C infection.

"The virus doesn't come in the organ itself. It's not in the heart or in the lung. It comes with the blood from the donor within the organ," Woolley explained.

More than 4 out of 5 people who received organs in the past from hepatitis C-positive donors wound up with a chronic infection themselves, researchers said in background notes. This not only threatened the health of their livers, but in some cases damaged their new organ.

The new transplant protocol calls for recipients to receive hepatitis C antivirals starting a few hours after leaving the operating room, Woolley said. Rather than wait for the patient to develop an infection, doctors instead head hep C off at the pass.

"It blocks the viral replication from occurring," Woolley said. "The virus needs time to get to the liver to set up shop and replicate there. By starting treatment right away, all the recipient is exposed to is a very low level of virus from the donor."

Since the recipients are exposed to only a tiny amount of virus, they don't have to undergo a full 12-week regimen of antivirals like people who've had chronic hepatitis C for months or years, Woolley said.

Instead, people who get a hep C-positive organ only have to take a four-week course of antivirals costing about $25,000, Woolley said.

The report, published April 3 online in the New England Journal of Medicine, said that 44 patients were initially enrolled in the study, including eight people who received new hearts and 36 who received new lungs.

But given the study's success, enrollment has continued and a total of 69 people have received hepatitis C-positive organs to date.

About 42 of the initial 44 patients in the program had a detectable hepatitis C viral load immediately following transplant, but the amount of virus declined to the point of being undetectable within about two weeks, the report said.

Woolley believes that this could become a new standard for transplants, particularly if the heavy cost of antiviral drugs continues to decrease the longer they are on the market.

Dr. Emily Blumberg, director of transplant infectious diseases at Penn Medicine, said the new protocol "has the potential to be a big advance, because currently there is a pretty sizeable number of individuals who have hepatitis C who are potential organ donors."

The drug regimen was not associated with any toxic effects, but doctors will have to be careful to track potential drug interactions, Blumberg said. For example, the antivirals can have interactions with statins and with certain heart medications.

"Most of the drug interactions are manageable, and we think the sooner you can start the medication, the better the potential for clearing the infection faster," said Blumberg, who wrote an editorial accompanying the study.

Doctors will need to keep tracking the progress of these patients to show that the safety of the process is long-term, she said.

The next step to making this standard care is to make sure that insurance companies will cover the cost of the antiviral treatment, Blumberg said.

"We need to be able to assure patients they will have real access to the drugs," Blumberg said. "Some companies are committed to providing the treatment, and some are not."

More information

The United Network for Organ Sharing has more about transplant statistics.




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net